Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction

Chun Shing Kwok1, Chris P Gale2, Tim Kinnaird1,3

  • 1Keele Cardiovascular Research Group, Keele University, Keele, Staffordshire, UK.

Insights

During COVID-19, primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England decreased. However, in-hospital outcomes for STEMI patients remained unaffected despite longer symptom-to-hospital and door-to-balloon times.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The COVID-19 pandemic significantly impacted healthcare systems globally.
  • Understanding its effect on acute cardiovascular interventions like primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is crucial.

Purpose of the Study:

  • To analyze changes in primary PCI procedural volumes for STEMI in England during the COVID-19 pandemic.
  • To assess the impact of these changes on patient clinical characteristics and in-hospital outcomes.

Main Methods:

  • A retrospective cohort study utilizing the British Cardiovascular Intervention Society-National Institute of Cardiovascular Outcomes Research database.
  • Analysis included 44 hospitals reporting PCI activity between January 2017 and April 2020, focusing on primary PCI for STEMI patients.

Main Results:

  • A 43% decline in monthly primary PCI procedures for STEMI was observed in April 2020 compared to the 2017-2019 average.
  • Median symptom-to-hospital and door-to-balloon times increased post-lockdown.
  • No significant difference in in-hospital mortality or major adverse cardiovascular events was found after adjusting for baseline characteristics.

Conclusions:

  • The COVID-19 lockdown in England led to a reduction in primary PCI procedures for STEMI and increased patient delays.
  • Despite these challenges, the restructuring of health services did not adversely affect in-hospital outcomes for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
475
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
134
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
249
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
120
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
155
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
710